Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Radical Autoxidation01:20

Radical Autoxidation

The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Ethics of Clinical Research on Diseases of the Fetus and Newborn: Balancing Benefit-Risk, Autonomy, and Maternal-Fetal Interests.

American journal of perinatology·2025
Same author

Small language models enable rapid and accurate extraction of structured data from unstructured text: An example with plants and their specialized metabolites.

Quantitative plant biology·2025
Same author

A new spin on chemotaxonomy: Using non-proteogenic amino acids as a test case.

Applications in plant sciences·2025
Same author

A prospective patient registry to monitor safety, effectiveness, and utilisation of bedaquiline in patients with multidrug-resistant tuberculosis in South Korea.

BMC infectious diseases·2023
Same author

Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis.

BMC infectious diseases·2022
Same author

Reply to the Comment on "Structural characterization of dissolved organic matter: a review of current techniques for isolation and analysis" by E. C. Minor, M. M. Swenson, B. M. Mattson, and A. R. Oyler, Environ. Sci.: Processes Impacts, 2014, 16, 2064.

Environmental science. Processes & impacts·2015

Related Experiment Video

Updated: Jun 27, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

Mass balance in rapamycin autoxidation.

Alan R Oyler1, Barbara L Armstrong, Richard Dunphy

  • 1University of Minnesota Duluth, Duluth, MN 55812, USA. aoyler@d.umn.edu

Journal of Pharmaceutical and Biomedical Analysis
|November 21, 2008
PubMed
Summary

Rapamycin, an immunosuppressant, degrades into many products, complicating analysis. A validated mass balance method using SEC and RP-HPLC effectively tracks drug loss and product formation in drug-eluting stents.

More Related Videos

Development and Application of Rapamycin-regulated Tyrosine Phosphatases
06:56

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

Published on: September 6, 2024

Preparation of Mitochondrial Enriched Fractions for Metabolic Analysis in Drosophila
08:22

Preparation of Mitochondrial Enriched Fractions for Metabolic Analysis in Drosophila

Published on: September 30, 2015

Related Experiment Videos

Last Updated: Jun 27, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

Development and Application of Rapamycin-regulated Tyrosine Phosphatases
06:56

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

Published on: September 6, 2024

Preparation of Mitochondrial Enriched Fractions for Metabolic Analysis in Drosophila
08:22

Preparation of Mitochondrial Enriched Fractions for Metabolic Analysis in Drosophila

Published on: September 30, 2015

Area of Science:

  • Pharmaceutical Sciences
  • Analytical Chemistry
  • Natural Product Chemistry

Background:

  • Rapamycin, a natural product immunosuppressant, is prone to autoxidation.
  • Degradation leads to complex mixtures of monomeric and oligomeric compounds.
  • This complexity poses challenges for mass balance in forced degradation studies and analysis of aged drug-eluting stents.

Purpose of the Study:

  • To develop and validate a mass balance methodology for quantifying rapamycin and its autoxidation products.
  • To address challenges in analyzing aged drug-eluting stents containing degraded rapamycin.
  • To establish a reliable method for accounting for drug loss and product formation.

Main Methods:

  • Utilized Size Exclusion Chromatography (SEC) with UV and Refractive Index detection.
  • Employed Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC).
  • Combined SEC and RP-HPLC to account for drug loss and formation of degradation products.

Main Results:

  • A robust mass balance methodology was successfully developed and validated.
  • The method accurately determined rapamycin and its composite autoxidation products in developmental stent samples.
  • The approach effectively accounted for drug loss and the formation of numerous degradation products.

Conclusions:

  • The validated mass balance approach provides accurate quantification of rapamycin degradation.
  • This methodology is crucial for analyzing aged drug-eluting stents.
  • The approach has potential broad applicability for analyzing other drugs that degrade into numerous products.